Product Information
NEUPOGEN 300 MCG/0.5 ML SYR is a brand product labeled by Amgen Inc., priced at $651.0520 per ML under NDC 55513092491. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
300 ug/.5mL
Manufacturer
Amgen Inc.NDC
55513092491
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
11/19/2025
Active Ingredients
FILGRASTIMApproval Type
Biologic (BLA)
FDA Application
BLA103353On Market Since
10/2/2000
Pharmacological Classes
Price Statistics
The NADAC for NEUPOGEN 300 MCG/0.5 ML SYR has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $651.0520 per ML |
|---|---|
| All-time high | $651.0520 (Jun 24, 2026) |
| All-time low | $648.6633 (May 22, 2024) |
| 52-week high | $651.0520 |
| 52-week low | $650.4967 |
| Median price | $650.5286 |
| Average price | $650.1640 |
| Largest weekly change | +0.2% (Dec 18, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NEUPOGEN 300 MCG/0.5 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for NEUPOGEN 300 MCG/0.5 ML SYR, manufactured by Amgen Inc., is $651.0520 per ML (NDC 55513092491), effective Jun 24, 2026.
How has the price of NEUPOGEN 300 MCG/0.5 ML SYR changed over time?
Over the history we have for it, the NADAC for NEUPOGEN 300 MCG/0.5 ML SYR has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for NEUPOGEN 300 MCG/0.5 ML SYR?
Since Apr 17, 2024, the NADAC for NEUPOGEN 300 MCG/0.5 ML SYR has ranged from a low of $648.6633 (May 22, 2024) to a high of $651.0520 (Jun 24, 2026), with a median of $650.5286 per ML.
Are there cheaper alternatives to NEUPOGEN 300 MCG/0.5 ML SYR?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, NEUPOGEN 300 MCG/ML VIAL, is $304.3070 per ML — about 53% below NEUPOGEN 300 MCG/0.5 ML SYR.
Who manufactures NEUPOGEN 300 MCG/0.5 ML SYR?
NEUPOGEN 300 MCG/0.5 ML SYR (NDC 55513092491) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification